Evoke Pharma Inc Quarterly Nonoperating Income (Expense) in USD from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Evoke Pharma Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2012 to Q2 2024.
  • Evoke Pharma Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$43.7K, a 47.7% increase year-over-year.
  • Evoke Pharma Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$312K, a 14.7% increase year-over-year.
  • Evoke Pharma Inc annual Nonoperating Income (Expense) for 2023 was -$361K, a 17.5% increase from 2022.
  • Evoke Pharma Inc annual Nonoperating Income (Expense) for 2022 was -$438K, a 13.4% decline from 2021.
  • Evoke Pharma Inc annual Nonoperating Income (Expense) for 2021 was -$386K, a 260% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$312K -$43.7K +$39.8K +47.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$352K -$78.6K +$9.36K +10.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$361K -$99.5K -$6.04K -6.47% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
Q3 2023 -$355K -$90.5K +$10.8K +10.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$366K -$83.5K +$37.3K +30.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$403K -$88K +$34.5K +28.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$438K -$93.4K +$31.6K +25.3% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 -$470K -$101K +$23.3K +18.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$493K -$121K +$899 +0.74% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$494K -$122K -$107K -714% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$386K -$125K -$66.2K -113% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 -$320K -$125K -$75.1K -152% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$245K -$122K -$119K -4908% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$126K -$15K -$18.4K -545% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$107K -$58.8K -$64.7K -1091% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$42.6K -$49.5K -$58.1K -676% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $15.5K -$2.43K -$12.1K -125% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $27.5K $3.38K -$1.25K -27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $28.8K $5.93K -$1.86K -23.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $30.7K $8.6K +$5.51K +178% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $25.1K $9.64K +$6.74K +232% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $18.4K $4.63K -$430K -98.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $449K $7.79K -$2.34M -99.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $2.79M $3.09K +$1.54M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.25M $2.9K -$1.26M -99.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $2.51M $435K +$3.51M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$999K $2.35M +$1.55M +195% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$2.55M -$1.54M -$685K -80.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$1.87M $1.26M +$1.34M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$3.2M -$3.07M -$3M -4132% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$204K $797K +$870K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$1.07M -$856K -$778K -998% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$296K -$72.7K +$3.91K +5.11% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$300K -$72.6K +$2.95K +3.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$303K -$73.1K -$67.7K -1253% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$235K -$78K -$73.8K -1764% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$162K -$76.6K -$21.4K -38.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$140K -$75.5K -$42.6K -130% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$97.6K -$5.4K +$30.5K +85% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$128K -$4.18K -$3.87K -1244% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$124K -$55.2K -$18.7K -51.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$106K -$32.9K +$129K +79.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$235K -$35.9K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-04
Q3 2013 -$311 +$8.19K +96.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$36.4K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$162K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 -$8.51K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.